Cite
HARVARD Citation
Van Hulst, G. et al. (2022). Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma. European respiratory journal. 59 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Van Hulst, G. et al. (2022). Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma. European respiratory journal. 59 (3), p. . [Online].